Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Areas
Cover Stories
Looking Backward to Go Forward
GSK’s Anne Phillips tells NGP why drug discovery should follow from the patient’s needs, rather than the other way around.
Turbulence Ahead
Robert Spiegel shares his views on transparency, health-care reform and the notorious failure of Vytorin. He is Schering-Plough’s Chief...
Roundtables
-
The Effectiveness of Branding
With Artcraft Health Education’s Marc Sirockman, Guard Dog’s Camille DeSantis and Maria Casini, and Lisa Kindig of Hall & PartnersRead more
Vendor Perspectives
-
Success Beyond Silos in Social Media
Maintaining an objective posture helps ensure that customer concerns, not team politics, drive brand development. By GuardDog Brand DevelopmentRead more -
Hard Times; Tough Choices
By CS International. Deployment planning and execution for any Continuous Improvement effort is critical to the viability of the deployment. Even when economic times get...Read more -
Single-use Sensors for Upstream Applicat...
By Finesse. One of the largest factors limiting the proliferation of single-use bioreactors in cGMP and production environments is the lack of reliable and well engineered...Read more -
Abuse Liability Testing: Safety versus D...
By MPI Research. The international community has long recognized the danger involved in the manufacture, distribution, and use of certain psychoactive substances for...Read more -
Contextual Cellular Analysis Powers Phar...
By Beckman Coulter. Cell-based analysis of potential therapeutic targets and vaccines provides researchers with the high level data required to make informed decisions...Read more -
Is Anyone Listening? The New Paradigm in...
By Hardrada Medica Group. As Sales & Marketing Executives striving to put together effective programs to reach physicians, we need to re-orient our thinking away from a...Read more
Industry Analysts
-
Laboratory Asset Management Strategies
Masao Moriyama explains how using a single provider for the management of laboratory equipment throughout its entire lifecycle reduces administration, improves efficiency...Read more -
RNA Biomarkers in Clinical Trials
Arguably, RNA is the earliest biological measure of disease, providing a relevant signal of disease onset or progression before observable clinical manifestations.Read more -
Crisis – the Opportunity
The current economic crisis is on everyone’s mind, even though the healthcare sector seems to be weathering the storm relatively well. By Paul-André de Lame, Anabase...Read more -
Customized Training
Why one-size-fits-all doesn’t work for today’s organizations. By Tom Mattus, Successful Strategies International, Inc.Read more
Executive Interviews
Trial and Error
Beth Harper of Clinical Performance Partners, Inc. explains the correct procedures needed to ensure a successful clinical study.
Read more
New Commercial Models
Sati Sian of IMS Health discusses the industry’s development of new commercial models.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.